Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…total of 339 patients, mostly Caucasian (91.4%), diagnosed with SLE were included in the study ( table 1), with a mean age of 53.2±…
…cioeconomic screening and support strategies into comprehensive SLE management and policy frameworks.…
…r disease (CVD). Literature on the matter is scarce and because Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) mainly affect women o…
…Objectives Systemic Lupus Erythematosus (SLE) is characterised by pronounced clinical and immunological…
… through July 2025. To assess Belimumab’s efficacy, we recorded SLE Disease Activity (SLEDAI), daily prednisolone-equivalent dose, …
…Objectives Cutaneous manifestations are common in systemic lupus erythematosus (SLE) and substantially contribute to disease burden. The Cutan…
…icoids (CG) use is a main driver of organ damage progression in Systemic Lupus Erythematosus (SLE). Updated EULAR SLE recommendations suggest avoiding the c…
…use. LC5 may provide a practical, structured method to identify SLE patients requiring therapeutic optimization, meriting validatio…
…ive observational study including patients aged > 18 years with systemic lupus erythematosus (SLE) who initiated anifrolumab between October 2023 and Octobe…
…ertiary centre (UCLH).Methods A retrospective analysis included SLE patients treated with belimumab (n=25), obinutuzumab (n=8), and…